Changing Patterns of Thalassemia Worldwide

@article{Vichinsky2005ChangingPO,
  title={Changing Patterns of Thalassemia Worldwide},
  author={Elliott Vichinsky},
  journal={Annals of the New York Academy of Sciences},
  year={2005},
  volume={1054}
}
  • E. Vichinsky
  • Published 2005
  • Medicine
  • Annals of the New York Academy of Sciences
Abstract: Thalassemia is a growing global public health problem with an estimated 900,000 births of clinically significant thalassemia disorders expected to occur in the next 20 years. This growth will occur in disorders previously uncommon in many parts of the world. In particular, hemoglobin (Hb) E‐β‐thalassemia and Hb H disease account for much of the projected increases in thalassemia. Worldwide, Hb E‐β‐thalassemia is one of the most frequent hemoglobinopathies. The incidence of Hb E… Expand
Alpha-thalassemia
TLDR
Usually, patients with hemoglobin H disease are clinically well and survive without any treatment, but occasional red blood cell transfusions may be needed if the hemoglobin level suddenly drops because of hemolytic or aplastic crisis likely due to viral infections. Expand
A Review on Epidemiology and Thalassemia Distribution, in Relevance to United Arab Emirates Population
Corresponding Author: Pooja Shivappa Department of Basic Sciences, RAK Medical and Health Sciences University, UAE Email: pooja@rakmhsu.ac.ae Abstract: Thalassemia is a blood disorder passed downExpand
Prevalence of α-Thalassemia in the Egyptian Population
TLDR
The deletional spectrum of α-thal is determined, which might be used in the future for molecular investigations of the disease in susceptible patients in the authors' population. Expand
β-Thalassemia: From Clinical Symptoms to the Management
Thalassemia is a single gene disorder is characterised by reduction or absence of beta-globin chain. It is commomest in the Middle East, Southeast Asia, African and some Asian countries includingExpand
Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated
TLDR
It is discovered that the prevention measures can contribute to reduce the prevalence of the disease only in the short term but not eradicate the disease in the long term. Expand
Beta-thalassemia
TLDR
Prognosis for individuals with beta-thalassemia has improved substantially in the last 20 years following recent medical advances in transfusion, iron chelation and bone marrow transplantation therapy, however, cardiac disease remains the main cause of death in patients with iron overload. Expand
Beta thalassemia - a review
TLDR
Hematopoietic stem cell transplantation is the only available curative approach for Thalassemia and programs that provide acceptable care, including transfusion of safe blood and supportive therapy including chelation must be established. Expand
Hemoglobin E disease in North Indian population: A report of 11 cases
TLDR
The main aim is to increase the awareness of this relatively rare disorder, so that it can be included in the differential diagnosis of patients presenting clinically like thalassemia intermedia or thAlassemia major, and help in prenatal diagnosis, genetic counseling and clinical management. Expand
Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy
  • E. Vichinsky
  • Medicine
  • Annals of the New York Academy of Sciences
  • 2010
TLDR
Alpha thalassemia major, a usually fatal in utero disease, is now recognized to have a complex molecular and phenotypic expression with increasing births being reported. Expand
Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis
TLDR
Hydroxyurea (HU), an oral chemotherapeutic drug, is expected to decrease disease severity and may benefit patients with Hb E/β-thalassemia, though large RCTs assessing efficacy should be conducted to confirm the findings of this meta-analysis and to assess long-term toxicity and response sustainability. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Clinical and hematologic aspects of hemoglobin E beta-thalassemia.
TLDR
A remarkable variability in the clinical expression, ranging from a mild form of thalassemia intermedia to transfusion-dependent conditions, is observed. Expand
Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem.
TLDR
This work states that a-thalassemia is the most common cause of fetal hydrops, and that fetuses without a-globin genes would suffer from severe anemia, and thus hypoxia, heart failure, and hydrops fetalis syndrome. Expand
Asian Immigration and Public Health in California: Thalassemia in Newborns in California
  • F. Lorey
  • Medicine
  • Journal of pediatric hematology/oncology
  • 2000
TLDR
Increases in Asian immigration and births in the U.S., particularly California, have been dramatic during the past 10 years and have led to detection of previously rare diseases like Hb E/&bgr;-thalassemia and Hb H disease, which previously affected mainly individuals of Mediterranean origin. Expand
The hypercoagulable state in thalassemia.
TLDR
The presence of a higher than normal incidence of thromboembolic events, mainly in beta-TI, and the existence of prothrombotic hemostatic anomalies in the majority of the patients, even from a very young age, have led to the recognition of the existence a chronic hypercoagulable state in thalassemic patients. Expand
Global Epidemiology of Hemoglobin Disorders
Abstract: Thalassemias and the hemoglobinopathies such as Hemoglobins S, C and E, are now a global problem. They have spread through migration from their native areas in the Mediterranean, Africa andExpand
Prevalence and genotypes of alpha‐ and beta‐thalassemia carriers in Hong Kong — Implications for population screening
TLDR
A community-based program of education, screening, and counseling is needed in Hong Kong and southern China because many women carrying fetuses at risk for thalassemia are not referred for genetic counseling. Expand
Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia.
TLDR
It is found that AHSP is not a disease modifier in Hb E-beta thalassemia, and it remains to be seen if any association between AHSP and clinical severity is present in other population groups with a high frequency of alpha globin gene mutations. Expand
Universal newborn screening for Hb H disease in California.
Newborn screening is an accepted public health measure to ensure that appropriate health care is provided in a timely manner to infants with hereditary/metabolic disorders. Alpha-thalassemia is aExpand
The unusual pathobiology of hemoglobin constant spring red blood cells.
TLDR
It is proposed that the membrane pathology of HbCS variants is caused by combination of the deleterious effects induced by membrane-bound oxidized alpha cs- and beta-globin chains, and each globin chain, alpha cs, alpha A, beta A, Beta A appears to produce its own form of membrane perturbation. Expand
Thalassemia in Sri Lanka: a progress report.
TLDR
A long-term observational study of patients with different forms of thalassemia in Sri Lanka suggests that in addition to the well-defined primary, secondary and tertiary genetic modifiers, environmental factors, particularly malaria, and variation in the ability to adapt to the profound anaemia which characterizes these conditions, may play a significant role in determining their clinical severity. Expand
...
1
2
3
4
...